FDA Expands Unannounced Inspections of Foreign Manufacturing Facilities - In Compliance Magazine

FDA Expands Unannounced Inspections of Foreign Manufacturing Facilities - In Compliance Magazine

The U.S. Food and Drug Administration (FDA) is stepping up its use of unannounced inspections at foreign manufacturing facilities that produce medicines and other medical products. The post FDA Expands Unannounced Inspections of Foreign Manufacturing Facilities appeared first on In Compliance Magazine.

Unannounced Inspections of Drug Manufacturers Could Improve Drug Safety — If It Actually Happens - MedShadow Foundation | Independent Health & Wellness Journalism

On May 5, 2025, President Trump issued an executive order aimed at increasing domestic medication production. In addition to removing regulatory barriers for domestic manufacturers, the order included an intention to conduct more unannounced inspections of overseas laboratories to match the level of scrutiny the country currently gives to domestic laboratories. Despite this new directive, “our dependency on foreign sources for pharmaceuticals is…